Platform Study of VSV-Based Recombinant Oncolytic Viruses for the Treatment of Advanced Malignant Tumors

NCT07656116 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

BIOLOGICAL: VSV injection

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences